CO-ADD will be present at the BIO convention in San Francisco for the Innovation Medicines Initiative (IMI) panel discussion on the alignment of global anti-infective research and development to the patient on Monday 06 June 2016.

Join the partnership this June at the 2016 BIO International Convention in San Francisco, California, when IMI ENABLE and CO-ADD present a panel of key experts to address the critical issue of anti-infective development and the need for global alignment throughout the development chain.

Panel Title: Alignment of global anti-infective research and development to the patient

Panel speakers: Tim Jinks, The Wellcome Trust Innovations Division Senior Business Analyst; Carolyn Shore, The Pew Charitable Trust Officer; Pamela Tenaerts, Duke University Executive Director, Clinical Trials Transformation Project; and Pierre Meulien, Innovative Medicines Executive Director.

CO-ADD's Matt Cooper and Mathilde Desselle will be present and available for meetings.